238 results on '"Potempa, Lawrence A."'
Search Results
2. Conformational state of C-reactive protein is critical for reducing immune complex-triggered type I interferon response: Implications for pathogenic mechanisms in autoimmune diseases imprinted by type I interferon gene dysregulation
3. mCRP-Induced Focal Adhesion Kinase-Dependent Monocyte Aggregation and M1 Polarization, Which Was Partially Blocked by the C10M Inhibitor
4. Secretory quality control constrains functional selection-associated protein structure innovation
5. Monomeric C reactive protein (mCRP) regulates inflammatory responses in human and mouse chondrocytes
6. Monomeric C-reactive protein as a biomarker for major depressive disorder
7. C-Reactive Protein and Its Structural Isoforms: An Evolutionary Conserved Marker and Central Player in Inflammatory Diseases and Beyond
8. The Influences of ApoE Isoforms on Endothelial Adherens Junctions and Actin Cytoskeleton Responding to mCRP
9. A biofunctional review of C-reactive protein (CRP) as a mediator of inflammatory and immune responses: differentiating pentameric and modified CRP isoform effects
10. Extracellular vesicles opsonized by monomeric C-reactive protein (CRP) are accessible as autoantigens in patients with systemic lupus erythematosus and associate with autoantibodies against CRP
11. C-reactive protein in gallbladder diseases: diagnostic and therapeutic insights
12. Monomeric C‐reactive protein: A novel biomarker predicting neurodegenerative disease and vascular dysfunction
13. Fueling the flames of colon cancer – does CRP play a direct pro-inflammatory role?
14. Alkylating-Agent Cytotoxicity Associated with O6-Methylguanine
15. Evaluation of serum and ocular levels of membrane attack complex and C-reactive protein in CFH-genotyped human donors
16. Relevance of lipoproteins, membranes, and extracellular vesicles in understanding C-reactive protein biochemical structure and biological activities
17. Drugs to Treat Head and Neck Cancers: Mechanisms of Action
18. Monomeric C-reactive protein and Notch-3 co-operatively increase angiogenesis through PI3K signalling pathway
19. Topological Localization of Monomeric C-reactive Protein Determines Proinflammatory Endothelial Cell Responses
20. Solubilization and purification of recombinant modified C-reactive protein from inclusion bodies using reversible anhydride modification
21. Monomeric C‐reactive protein induces the cellular pathology of Alzheimer's disease
22. Modified C-reactive protein interacts with platelet glycoprotein Ibα
23. Monomeric C‐reactive protein via endothelial CD31 for neurovascular inflammation in an ApoE genotype‐dependent pattern: A risk factor for Alzheimer’s disease?
24. C-Reactive Protein and Cancer: Interpreting the Differential Bioactivities of Its Pentameric and Monomeric, Modified Isoforms
25. C-reactive protein and inflammation: conformational changes affect function
26. Binding of the monomeric form of C-reactive protein to enzymatically-modified low-density lipoprotein: Effects of phosphoethanolamine
27. Competition between distinct ApoE alleles and mCRP for the endothelial receptor CD31 differentially regulates neurovascular inflammation and Alzheimer’s disease pathology
28. Native C-reactive protein induces endothelial dysfunction in ApoE −/− mice: Implications for iNOS and reactive oxygen species
29. Corrigendum: Monomeric C-Reactive Protein Binds and Neutralizes Receptor Activator of NF-κB Ligand-Induced Osteoclast Differentiation
30. C-Reactive Protein and Cancer—Diagnostic and Therapeutic Insights
31. How C-Reactive Protein Structural Isoforms With Distinctive Bioactivities Affect Disease Progression
32. Monomeric C-reactive protein induces the cellular pathology of Alzheimer's disease.
33. Insights into the Use of C-Reactive Protein as a Diagnostic Index of Disease Severity in COVID-19 Infections
34. P106 Pentameric, but not monomeric C-reactive protein, limits the snRNP-immune complex triggered type I interferon response: implications for lupus pathogenesis
35. Modified C-Reactive Protein Is Expressed by Stroke Neovessels and Is a Potent Activator of Angiogenesis In Vitro
36. Tubular staining of modified C-reactive protein in diabetic chronic kidney disease
37. TUBULAR STAINING OF MODIFIED C-REACTIVE PROTEIN INCREASES WITH SEVERITY OF DIABETIC NEPHROPATHY
38. Immunohistochemical Localization of Modified C-Reactive Protein Antigen in Normal Vascular Tissue
39. A redox sensitivity-based method to quantify both pentameric and monomeric C-reactive protein in a single assay
40. Monomeric C-reactive protein and inflammation in age-related macular degeneration
41. Matrix sieving-enforced retrograde transcytosis regulates tissue accumulation of C-reactive protein
42. Dissociation of C-Reactive Protein Localizes and Amplifies Inflammation: Evidence for a Direct Biological Role of C-Reactive Protein and Its Conformational Changes
43. A Conformational Change in C-Reactive Protein Enhances Leukocyte Recruitment and Reactive Oxygen Species Generation in Ischemia/Reperfusion Injury
44. C-Reactive Protein As a Mediator of Complement Activation and Inflammatory Signaling in Age-Related Macular Degeneration
45. Monomeric C-Reactive Protein Binds and Neutralizes Receptor Activator of NF-κB Ligand-Induced Osteoclast Differentiation
46. Conformational folding and disulfide bonding drive distinct stages of protein structure formation
47. Common Angiogenic Signaling Pathways Induced by Monomeric C - reactive protein and FGF-2 through MAPK and PI3K
48. Transitional changes in the CRP structure lead to the exposure of proinflammatory binding sites
49. Monomeric C-reactive protein and inflammation in age-related macular degeneration
50. Matrix sieving-enforced retrograde transcytosis regulates tissue accumulation of C-reactive protein.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.